| PENUMBRA INC. |
| USA |
| Gesundheit |
| US70975L1070 / A14Y65 |
| 0P8 (Frankfurt) / PEN (NYSE) |
| FRA:0P8, ETR:0P8, 0P8:GR, NYSE:PEN |
| - |
| https://www.penumbrainc.c.. |
|
Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the company operates within the specialized field of int..
>Volltext.. |
| 10922.39 Mio. EUR |
| 10532.22 Mio. EUR |
| 1288.93 Mio. EUR |
| 175.14 Mio. EUR |
| 137.54 Mio. EUR |
| 3.51 EUR |
| 182.19 Mio. EUR |
| 175.81 Mio. EUR |
| 237.94 Mio. EUR |
| 2.82 |
| 21.25% |
| 12.14% |
| - |
| - |
| - |
| - |
| PENUMBRA |
| 26.08.26 |
|